OrthoPediatrics Corp.

NasdaqGM:KIDS 주식 보고서

시가총액: US$549.5m

OrthoPediatrics 관리

관리 기준 확인 3/4

OrthoPediatrics CEO는 David Bailey, Jun2020 에 임명되었습니다 의 임기는 4.42 년입니다. 총 연간 보상은 $ 2.72M, 18.4% 로 구성됩니다. 18.4% 급여 및 81.6% 보너스(회사 주식 및 옵션 포함). 는 $ 5.21M 가치에 해당하는 회사 주식의 0.95% 직접 소유합니다. 5.21M. 경영진과 이사회의 평균 재임 기간은 각각 4.1 년과 12.8 년입니다.

주요 정보

David Bailey

최고 경영자

US$2.7m

총 보상

CEO 급여 비율18.4%
CEO 임기4.4yrs
CEO 소유권0.9%
경영진 평균 재임 기간4.1yrs
이사회 평균 재임 기간12.8yrs

최근 관리 업데이트

Recent updates

Investors Still Waiting For A Pull Back In OrthoPediatrics Corp. (NASDAQ:KIDS)

Nov 05
Investors Still Waiting For A Pull Back In OrthoPediatrics Corp. (NASDAQ:KIDS)

The OrthoPediatrics Corp. (NASDAQ:KIDS) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Aug 09
The OrthoPediatrics Corp. (NASDAQ:KIDS) Second-Quarter Results Are Out And Analysts Have Published New Forecasts

Shareholders Should Be Pleased With OrthoPediatrics Corp.'s (NASDAQ:KIDS) Price

Aug 02
Shareholders Should Be Pleased With OrthoPediatrics Corp.'s (NASDAQ:KIDS) Price

OrthoPediatrics Corp. (NASDAQ:KIDS) Just Reported And Analysts Have Been Lifting Their Price Targets

May 09
OrthoPediatrics Corp. (NASDAQ:KIDS) Just Reported And Analysts Have Been Lifting Their Price Targets

OrthoPediatrics (NASDAQ:KIDS) Has Debt But No Earnings; Should You Worry?

May 07
OrthoPediatrics (NASDAQ:KIDS) Has Debt But No Earnings; Should You Worry?

Why Investors Shouldn't Be Surprised By OrthoPediatrics Corp.'s (NASDAQ:KIDS) P/S

Apr 10
Why Investors Shouldn't Be Surprised By OrthoPediatrics Corp.'s (NASDAQ:KIDS) P/S

Why Investors Shouldn't Be Surprised By OrthoPediatrics Corp.'s (NASDAQ:KIDS) P/S

Dec 20
Why Investors Shouldn't Be Surprised By OrthoPediatrics Corp.'s (NASDAQ:KIDS) P/S

Getting In Cheap On OrthoPediatrics Corp. (NASDAQ:KIDS) Might Be Difficult

May 05
Getting In Cheap On OrthoPediatrics Corp. (NASDAQ:KIDS) Might Be Difficult

OrthoPediatrics' (NASDAQ:KIDS) Earnings Aren't As Good As They Appear

Nov 08
OrthoPediatrics' (NASDAQ:KIDS) Earnings Aren't As Good As They Appear

OrthoPediatrics announces public offering of stock, pre-funded warrants

Aug 10

Is OrthoPediatrics (NASDAQ:KIDS) Using Debt In A Risky Way?

Aug 08
Is OrthoPediatrics (NASDAQ:KIDS) Using Debt In A Risky Way?

OrthoPediatrics enters distribution agreement with 3D-Side

Jul 13

CEO 보상 분석

David Bailey 의 보수는 OrthoPediatrics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Sep 30 2024n/an/a

-US$28m

Jun 30 2024n/an/a

-US$25m

Mar 31 2024n/an/a

-US$22m

Dec 31 2023US$3mUS$500k

-US$21m

Sep 30 2023n/an/a

-US$22m

Jun 30 2023n/an/a

US$976k

Mar 31 2023n/an/a

US$4m

Dec 31 2022US$1mUS$415k

US$1m

Sep 30 2022n/an/a

US$9m

Jun 30 2022n/an/a

-US$12m

Mar 31 2022n/an/a

-US$15m

Dec 31 2021US$906kUS$371k

-US$16m

Sep 30 2021n/an/a

-US$30m

Jun 30 2021n/an/a

-US$33m

Mar 31 2021n/an/a

-US$38m

Dec 31 2020US$898kUS$371k

-US$33m

Sep 30 2020n/an/a

-US$23m

Jun 30 2020n/an/a

-US$22m

Mar 31 2020n/an/a

-US$15m

Dec 31 2019US$836kUS$300k

-US$13m

Sep 30 2019n/an/a

-US$11m

Jun 30 2019n/an/a

-US$10m

Mar 31 2019n/an/a

-US$10m

Dec 31 2018US$590kUS$266k

-US$12m

Sep 30 2018n/an/a

-US$25m

Jun 30 2018n/an/a

-US$26m

Mar 31 2018n/an/a

-US$26m

Dec 31 2017US$483kUS$258k

-US$24m

보상 대 시장: David 의 총 보상 ($USD 2.72M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 2.22M ).

보상과 수익: 회사가 수익성이 없는 동안 David 의 보상이 증가했습니다.


CEO

David Bailey (45 yo)

4.4yrs

테뉴어

US$2,721,840

보상

Mr. David R. Bailey serves as the Chief Executive Officer at OrthoPediatrics Corp. since June 01, 2021. He serves as the President at OrthoPediatrics Corp. since June 3, 2020 and serves as its Director sin...


리더십 팀

이름위치테뉴어보상소유권
Mark Throdahl
Executive Chairman15.8yrs데이터 없음0.75%
$ 4.1m
David Bailey
President4.4yrsUS$2.72m0.95%
$ 5.2m
Fred Hite
CFO, Principal Financial & Accounting Officer9.8yrsUS$2.04m0.62%
$ 3.4m
Daniel Gerritzen
Executive VP of Legal15.8yrsUS$1.35m0.32%
$ 1.8m
Gregory Odle
President of Scoliosisno dataUS$1.35m0.48%
$ 2.6m
Kevin Unger
President of Enabling Technologies1.5yrsUS$22.50k데이터 없음
Joseph Hauser
President of Trauma & Deformity Correction3.8yrsUS$1.35m0.37%
$ 2.1m
Joel Batts
Senior Vice President of Clinical & Regulatory Affairs2.1yrs데이터 없음데이터 없음
Mark Karshner
Senior Vice President of International Sales8.8yrs데이터 없음데이터 없음

4.1yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 관리: KIDS 의 관리팀은 경험 ( 4.1 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Mark Throdahl
Executive Chairman15.8yrs데이터 없음0.75%
$ 4.1m
David Bailey
President3yrsUS$2.72m0.95%
$ 5.2m
Fred Hite
CFO, Principal Financial & Accounting Officer9.3yrsUS$2.04m0.62%
$ 3.4m
Terry Schlotterback
Lead Independent Director15.8yrsUS$185.00k0.086%
$ 471.2k
Peter Armstrong
Chair of Surgeon Advisory Boardno data데이터 없음데이터 없음
David Pelizzon
Director13.8yrsUS$180.00k0.10%
$ 557.0k
Bryan Hughes
Independent Director12.8yrsUS$190.00k0.053%
$ 291.0k
Henry Chambers
Member of Surgeon Advisory Boardno data데이터 없음데이터 없음
J. Gordon
Member of Surgeon Advisory Boardno data데이터 없음데이터 없음
H. Graham
Member of Surgeon Advisory Boardno data데이터 없음데이터 없음
Daniel Hoernschemeyer
Member of Surgeon Advisory Boardno data데이터 없음데이터 없음
Marie Infante
Independent Director10.8yrsUS$185.00k0.047%
$ 257.9k

12.8yrs

평균 재임 기간

68yo

평균 연령

경험이 풍부한 이사회: KIDS 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 12.8 년).